Home›Companies›Biotech & Pharma›Avant Sciences

Avant Sciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 29, 2024·Suggest an edit

About Avant Sciences

Avant Sciences is a private company based in New York, New York, incorporated in 2023 in Delaware. It has reported $175,000 raised in one offering on Form D since July 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 12, 2024Jul 29, 2024$175,000of $300K target5$35,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Avant Sciences's Form D filed Jul 29, 2024.

AD
Avnish Deobhakta
Executive officer and director
PL
Paul Lee
Executive officer and director

Sources

  1. SECAvant Sciences, Inc. filing history